Orange Book product · Generic (ANDA)
ETHOSUXIMIDE
ETHOSUXIMIDE
At a glance
Sep 25, 2012
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 25, 2012
13 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ETHOSUXIMIDE
Strength
250MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 200892
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ETHOSUXIMIDE
- —ZARONTINBrand (NDA)
NDA 012380 · PARKE DAVIS
- 2020ETHOSUXIMIDEGeneric (ANDA)
ANDA 210654 · PURACAP PHARM LLC
- 2019ETHOSUXIMIDEGeneric (ANDA)
ANDA 211928 · ONESOURCE SPECIALTY
- 2008ETHOSUXIMIDEGeneric (ANDA)
ANDA 040686 · EPIC PHARMA LLC
- 2003ETHOSUXIMIDEGeneric (ANDA)
ANDA 040506 · CHARTWELL RX
- 2002ETHOSUXIMIDEGeneric (ANDA)
ANDA 040430 · BIONPHARMA
- 2000ETHOSUXIMIDEGeneric (ANDA)
ANDA 040253 · PHARM ASSOC
- 1993ETHOSUXIMIDEGeneric (ANDA)
ANDA 081306 · TEVA PHARMS
- —ZARONTINGeneric (ANDA)
ANDA 080258 · PARKE-DAVIS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
